Our phopho-western blot data support that activating EphB4 while simultaneously avoiding activation of ephrinB2 using various therapeutic strategies such as the ephrinB2-Fc-His plasmid provides maximal benefit to reducing local tumor growth and distant metastases. Here, EFNB2 is linked to neoplasm.